Cargando…

Nucleosome binding by serum amyloid P component from SLE patients

Detalles Bibliográficos
Autores principales:	Heegaard, NHH, Rahbek, L, Recke, C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2001
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3273207/ http://dx.doi.org/10.1186/ar282

Ejemplares similares

Elevated anti-serum amyloid P component (SAP) antibodies in SLE patients
por: Zandman-Goddard, G, et al.
Publicado: (2003)

Characterization of binding interactions in solution between β-2-glycoprotein I and monoclonal antibodies
por: Heegaard, NHH, et al.
Publicado: (2002)

Serum amyloid P component (SAP) binds to late apoptotic cells and mediates their phagocytosis by macrophages
por: Bijl, M, et al.
Publicado: (2002)

SLE: insights from array-based proteomics
por: Wu, T, et al.
Publicado: (2012)

The role of DNA in the pathogenesis of SLE
por: Pisetsky, DS
Publicado: (2001)

Genetic analysis of the pentraxin genes in SLE
por: Russell, AI, et al.
Publicado: (2001)

Vasculitis and Systemic Lupus Erythematous (SLE)
por: Cortis, Elisabetta, et al.
Publicado: (2015)

Signalling via T cell receptor (TCR) in patients with SLE
por: Cebecauer, M, et al.
Publicado: (2001)

T lymphocytes of patients with SLE lack Stat4
por: Aringer, M, et al.
Publicado: (2001)

SLE risk alleles and cell development and activation
por: Kim, SJ, et al.
Publicado: (2012)

Clinical impact of biologic therapy in the treatment of SLE
por: Wallace, Daniel J
Publicado: (2013)

Regulatory natural autoantibodies suppress inflammation and SLE disease activity
por: Silverman, GJ, et al.
Publicado: (2012)

Neuropsychiatric events in SLE: determination of attribution and assessment of outcome
por: Hanly, JG
Publicado: (2012)

PROMISSE: progress in understanding pregnancy complications in patients with SLE
por: Salmon, JE
Publicado: (2012)

B cells at the adaptive-innate immune system interface in SLE
por: Anolik, JH, et al.
Publicado: (2012)

Serum amyloid-p (SAP), a potential biomarker for Down syndrome fetuses prevention in maternal plasma
por: Anagnostopoulos, Athanasios, et al.
Publicado: (2014)

Clinical and immunological effects of anti-TNF therapy in systemic lupus erythematosus (SLE)
por: Aringer, M, et al.
Publicado: (2003)

Immuno-serological profile of Systemic Erythemic Lupus (SLE) patients with neuropsychiatric manifestations (NP)
por: Stojanovich, L, et al.
Publicado: (2001)

Interplay of neutrophils and type I interferons in the development of end-organ damage in SLE
por: Kaplan, MJ
Publicado: (2012)

High score on PREDICTS is associated with 10-fold increased odds for the progression of subclinical atherosclerosis in SLE
por: McMahon, M, et al.
Publicado: (2012)

Comparison of different immunoassays detecting anti-chromatin autoantibodies in systemic lupus erythematosus (SLE)
por: Roux-Lombard, P, et al.
Publicado: (2002)

IRF5 expression profiling in SLE patients: new leads to a pathogenic signature?
por: Barnes, BJ, et al.
Publicado: (2012)

Aggregation of MAVS antiviral protein suggests a mechanism for increased type I interferon production in SLE
por: Shao, Wen-Hai, et al.
Publicado: (2014)

Nucleosome is a necrosis inducer for lymphocytes: consequences in systemic lupus erythematosus
por: Decker, P, et al.
Publicado: (2001)

MicroRNA-3148 modulates differential gene expression of the SLE-associated TLR7 variant
por: Deng, Y, et al.
Publicado: (2012)

Validating the expression of miRNAs in healthy controls and SLE patients and to predict possible gene targets
por: Chugha, Amandeep, et al.
Publicado: (2015)

Autoantibodies to the TNF-α translational regulators TIA-1 and TIAR occur frequently in sera of patients with SLE and scleroderma
por: Jimenez-Boj, E, et al.
Publicado: (2002)

Characterization of RA33 (hnRNP-A2/B1)-autoreactive T cells in SLE-patients
por: Fritsch, R, et al.
Publicado: (2001)

Mycophenolate mofetil prevents the development of a clinical relapse in SLE patients at risk: an open pilot study
por: Bijl, M, et al.
Publicado: (2002)

The association of HLA-DR/DQ coding and QBP promoter allelic polymorphism with antiphospholipid antibody response in SLE
por: Logar, D, et al.
Publicado: (2002)

Sociodemographic characteristics of SLE patients in a large metropolitan area with a high Afro-Caribbean population
por: Cabas-Vargas, J, et al.
Publicado: (2012)

Dominance of hydrophobic reading frames in complementarity determining region 3 of variable heavy chain genes from a patient with untreated SLE
por: Yazdani-Biuki, B, et al.
Publicado: (2001)

Binding specificity of serum amyloid P component for the pyruvate acetal of galactose
Publicado: (1984)

Effects of atacicept on disease activity in patients with moderate to severe systemic lupus erythematosus: APRIL-SLE randomized trial
por: Isenberg, David, et al.
Publicado: (2014)

Autoantibodies to hnRNP-A2 in SLE: identification of disease-specific linear epitopes and correlation with disease activity and clinical features
por: Schett, G, et al.
Publicado: (2003)

P02-015 - A novel MVK mutation in a child with AA amyloid
por: Kolsky, A, et al.
Publicado: (2013)

The nucleosome: from wallflower to Queen of the Ball
por: Cubizolles, Fabien, et al.
Publicado: (2001)

Skin-antigen specific antibodies are detected in UV irradiation and TLR7 agonist induced lupus-like disease in autoimmune prone NOD mice and in pediatric SLE
por: Ghoreishi, M, et al.
Publicado: (2012)

Induction of ANA, anti-dsDNA and anti-nucleosome antibodies following infliximab treatment in rheumatoid arthritis and spondyloarthropathy patients
por: de Rycke, LEB, et al.
Publicado: (2002)

SLE patients and autoantibody-positive healthy individuals display unique cytokine profiles: shared features of inflammation as well as select features of immunosuppression in autoantibody-positive healthy individuals
por: Ritterhouse, LL, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_p170n4425lkc5vvrgjb4q8ts7k